Health Care · Pharmaceutical Preparations · SIX Swiss Exchange · CIK 1114448 · FYE 12-31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $158.83Day −0.64%1Y +39.6%Off 52W high −6.8%Vol (1Y) 22.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 6,589 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Days to cover3.6d |
| Top-10 13F concentration47.4% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$54.53B |
| Earnings (TTM)$13.98B |
| ROE31.0% |
| Net margin25.6% |
| ROIC43.6% |
| Debt / equity0.01× |
| EPS growth 3Y31.1% |
| Sales growth 3Y8.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+18.7% |
| 1Y+39.6% |
| 3Y+77.5% |
| 5Y+107.8% |
| 10Y+206.9% |
| Since incept. (ann.)+9.6% |
Total return through 2026-07-29 · series begins 2000-05-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)22.0% |
| Ann. volatility (3Y)19.7% |
| Sharpe (1Y)1.69 |
| Sharpe (3Y)1.09 |
| Max drawdown (1Y)−12.6% |
| Max drawdown (3Y)−20.0% |
| Beta (3Y vs SPY)0.10 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Fisher Asset Management, LLC | 13.9M | $2.1B | 0.73% | +86.0% |
| MORGAN STANLEY | 8.5M | $1.3B | 0.45% | −3.9% |
| DIMENSIONAL FUND ADVISORS LP | 8.1M | $1.2B | 0.43% | −4.9% |
| PRIMECAP MANAGEMENT CO/CA/ | 7.6M | $1.2B | 0.40% | −0.2% |
| Dodge & Cox | 7.0M | $1.1B | 0.37% | −22.7% |
| GOLDMAN SACHS GROUP INC | 6.5M | $997M | 0.34% | +137.7% |
| LOOMIS SAYLES & CO L P | 5.4M | $829M | 0.28% | −2.0% |
| BANK OF AMERICA CORP /DE/ | 5.0M | $758M | 0.26% | +9.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for NVS.
